BioSpace News Archive

Career Advice

Words to Banish from Your Work Emails

Besides making sure you don’t accidentally reply all to that company-wide notice, here are some words to reserve for your texts with friends.

October 30, 2019
·
2 min read
·
Laura Brothers
Policy

FDA Places Partial Clinical Hold on Zolgensma Trial Over Safety Concerns

Novartis said it will work diligently with the FDA to resolve the partial clinical hold and resume the study.

October 30, 2019
·
2 min read
·
Alex Keown
FDA

FDA Approval of Vumerity for MS Triggers $150 Million Milestone Payment from Biogen to Alkermes

The approval was based on a New Drug Application (NDA) submitted under the 505(b)(2) filing pathway.

October 30, 2019
·
2 min read
·
Mark Terry
Policy

Based on Failed Confirmatory Trial, FDA Adcom Recommends Pulling AMAG’s Makena From the Market

Makena has been approved to decrease preterm birth in pregnant women with a previous spontaneous preterm birth.

October 30, 2019
·
3 min read
·
Mark Terry
Ranking the Top 10 Biotech Clusters in Europe

Although Boston and San Francisco are the biggest biotech clusters in the United States, Europe boasts its own set of hot spots for biopharma development.

October 30, 2019
·
7 min read
·
Mark Terry
Primary Endpoint met in Real-World Data Study Demonstrating Clinical Superiority of the Combination of Tafasitamab and Lenalidomide compared to Lenalidomide alone

MorphoSys AG announced topline results from the primary analysis of the retrospective observational matched control cohort This study was designed to compare the effectiveness of lenalidomide monotherapy based on real-world patient data with the efficacy outcomes of the tafasitamab/lenalidomide combination, as investigated in MorphoSys’s L-MIND trial

October 30, 2019
·
7 min read
Pharm Country

Alfa Chemistry Launched Microalgae Powder Services

Alfa Chemistry announced that it has launched microalgae powder production services.

October 30, 2019
·
4 min read
Business

MorphoSys AG Reports Third Quarter 2019 Financial Results

MorphoSys AG reported its financial results for the third quarter of 2019.

October 30, 2019
·
16 min read
Business

Evonik and Dow develop industrial-scale direct synthesis of propylene glycol from propylene and hydrogen peroxide

Dow and Evonik have entered into an exclusive technology partnership. Together, they plan to bring a unique method for directly synthesizing propylene glycol (PG) from propylene and hydrogen peroxide to market maturity.

October 30, 2019
·
5 min read
Genetown

Rho Experts Share Best Practices to Improve Diversity in Clinical Trials

Free webinar provides solutions to bridge the gap between underrepresented communities and clinical research

October 30, 2019
·
2 min read